Your browser doesn't support javascript.
loading
Lipid exchange of apolipoprotein A-I amyloidogenic variants in reconstituted high-density lipoprotein with artificial membranes.
Correa, Yubexi; Ravel, Mathilde; Imbert, Marie; Waldie, Sarah; Clifton, Luke; Terry, Ann; Roosen-Runge, Felix; Lagerstedt, Jens O; Moir, Michael; Darwish, Tamim; Cárdenas, Marité; Del Giudice, Rita.
Afiliação
  • Correa Y; Biofilm - Research Center for Biointerfaces and Department of Biomedical Science, Faculty of Health and Society, Malmö University, Malmö, Sweden.
  • Ravel M; Biofilm - Research Center for Biointerfaces and Department of Biomedical Science, Faculty of Health and Society, Malmö University, Malmö, Sweden.
  • Imbert M; Biofilm - Research Center for Biointerfaces and Department of Biomedical Science, Faculty of Health and Society, Malmö University, Malmö, Sweden.
  • Waldie S; Biofilm - Research Center for Biointerfaces and Department of Biomedical Science, Faculty of Health and Society, Malmö University, Malmö, Sweden.
  • Clifton L; ISIS Pulsed Neutron and Muon Source, Science and Technology Facilities Council, Rutherford Appleton Laboratory, Harwell Science and Innovation Campus, Didcot, UK.
  • Terry A; MAX IV Laboratory, CoSAXS Beamline, Lund University, Lund, Sweden.
  • Roosen-Runge F; Biofilm - Research Center for Biointerfaces and Department of Biomedical Science, Faculty of Health and Society, Malmö University, Malmö, Sweden.
  • Lagerstedt JO; Islet Cell Exocytosis, Department of Clinical Sciences in Malmö, Lund University Diabetes Centre, Lund University, Malmö, Sweden.
  • Moir M; Rare Endocrine Disorders, Research and Early Development, Novo Nordisk, Copenhagen, Denmark.
  • Darwish T; National Deuteration Facility, Australian Nuclear Science and Technology Organization (ANSTO), Lucas Heights, New South Wales, Australia.
  • Cárdenas M; National Deuteration Facility, Australian Nuclear Science and Technology Organization (ANSTO), Lucas Heights, New South Wales, Australia.
  • Del Giudice R; Faculty of Science and Technology, University of Canberra, Canberra, Australian Capital Territory, Australia.
Protein Sci ; 33(5): e4987, 2024 May.
Article em En | MEDLINE | ID: mdl-38607188
ABSTRACT
High-density lipoproteins (HDLs) are responsible for removing cholesterol from arterial walls, through a process known as reverse cholesterol transport. The main protein in HDL, apolipoprotein A-I (ApoA-I), is essential to this process, and changes in its sequence significantly alter HDL structure and functions. ApoA-I amyloidogenic variants, associated with a particular hereditary degenerative disease, are particularly effective at facilitating cholesterol removal, thus protecting carriers from cardiovascular disease. Thus, it is conceivable that reconstituted HDL (rHDL) formulations containing ApoA-I proteins with functional/structural features similar to those of amyloidogenic variants hold potential as a promising therapeutic approach. Here we explored the effect of protein cargo and lipid composition on the function of rHDL containing one of the ApoA-I amyloidogenic variants G26R or L174S by Fourier transformed infrared spectroscopy and neutron reflectometry. Moreover, small-angle x-ray scattering uncovered the structural and functional differences between rHDL particles, which could help to comprehend higher cholesterol efflux activity and apparent lower phospholipid (PL) affinity. Our findings indicate distinct trends in lipid exchange (removal vs. deposition) capacities of various rHDL particles, with the rHDL containing the ApoA-I amyloidogenic variants showing a markedly lower ability to remove lipids from artificial membranes compared to the rHDL containing the native protein. This effect strongly depends on the level of PL unsaturation and on the particles' ultrastructure. The study highlights the importance of the protein cargo, along with lipid composition, in shaping rHDL structure, contributing to our understanding of lipid-protein interactions and their behavior.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Apolipoproteína A-I / Lipoproteínas HDL Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Apolipoproteína A-I / Lipoproteínas HDL Idioma: En Ano de publicação: 2024 Tipo de documento: Article